{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:02:49Z","timestamp":1785240169980,"version":"3.55.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.hbpd.2025.10.010","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:30:09Z","timestamp":1761669009000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-invasive diagnostic biomarkers of viral hepatitis based on multi-omics technology: Recent advances and challenges"],"prefix":"10.1016","volume":"25","author":[{"given":"Xiang-Yan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Fang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Sen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2025.10.010_bib0001","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.987324","article-title":"Advances in multi-omics research on viral hepatitis","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0003","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/14737159.2018.1496020","article-title":"Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma","volume":"18","author":"Kotha","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0004","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14787210.2018.1505503","article-title":"Global epidemiology of viral hepatitis and national needs for complete control","volume":"16","author":"Lanini","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0005","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/microorganisms10112096","article-title":"Viral diagnosis of hepatitis B and delta: what we know and what is still required? Specific focus on low- and middle-income countries","volume":"10","author":"Ceesay","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0006","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.3390\/ijms23073897","article-title":"Viral hepatitis, cholesterol metabolism, and cholesterol-lowering natural compounds","volume":"23","author":"Liou","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jcp.57.1.1","article-title":"Guidelines for virological and non-viral serological examination of specimens in routine diagnostic microbiological laboratories","volume":"57","author":"Francis","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0008","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/CM9.0000000000001886","article-title":"Advances in the diagnosis and treatment of viral hepatitis B and C in China","volume":"135","author":"Jia","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0009","article-title":"Advances in multi-omics applications in HBV-associated hepatocellular carcinoma","volume":"8","author":"Cui","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0010","series-title":"The global prevalence of hepatitis A virus infection and susceptibility: a systematic review","author":"Jacobsen","year":"2009"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031807","article-title":"Hepatitis A virus capsid structure","volume":"9","author":"Stuart","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0012","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1016\/j.vaccine.2010.08.037","article-title":"Hepatitis A virus seroprevalence by age and world region, 1990 and 2005","volume":"28","author":"Jacobsen","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0013","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/ije\/dyi062","article-title":"The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns","volume":"34","author":"Jacobsen","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a031716","article-title":"Globalization and the changing epidemiology of hepatitis A virus","volume":"8","author":"Jacobsen","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0016","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/v15010214","article-title":"Recent advances in protective vaccines against hepatitis viruses: a narrative review","volume":"15","author":"Elbahrawy","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3748\/wjg.v28.i1.76","article-title":"Viral hepatitis in 2021: the challenges remaining and how we should tackle them","volume":"28","author":"Dunn","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2534856","article-title":"Alterations in cirRNA expression profile during the development of acute-on-chronic liver failure induced by hepatitis B","volume":"2022","author":"Lian","year":"2022","journal-title":"Adv Gut Microbiome Res"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0019","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jhep.2020.09.013","article-title":"A global investment framework for the elimination of hepatitis B","volume":"74","author":"Howell","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0020","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.hbpd.2024.08.007","article-title":"Chronic viral hepatitis B complicated by hepatitis E virus infection","volume":"24","author":"Yu","year":"2025","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0021","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/cid\/civ332","article-title":"Epidemiology of acute hepatitis B in the United States from population-based surveillance, 2006-2011","volume":"61","author":"Iqbal","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0022","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jhep.2022.12.014","article-title":"Discovery of a first-in-class orally available HBV cccDNA inhibitor","volume":"78","author":"Wang","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/4722047","article-title":"Hepatitis B: model systems and therapeutic approaches","volume":"2024","author":"Yu","year":"2024","journal-title":"J Immunol Res"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0024","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/occmed\/kqr136","article-title":"Hepatitis B prevention, diagnosis, treatment and care: a review","volume":"61","author":"Aspinall","year":"2011","journal-title":"Occup Med (Lond)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0025","first-page":"59","article-title":"Gut microbiota modulation: a viable strategy to address medical needs in hepatocellular carcinoma and liver transplantation","volume":"29","author":"Xiang","year":"2023","journal-title":"Engineering (Beijing)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2140886","article-title":"HBV genomic integration and hepatocellular carcinoma","volume":"2022","author":"Wang","year":"2022","journal-title":"Adv Gut Microbiome Res"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0027","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1128\/JVI.00991-15","article-title":"Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion","volume":"89","author":"Falson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0028","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0029","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/gutjnl-2016-311726","article-title":"Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture","volume":"66","author":"Piver","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Collaborators","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0031","series-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","year":"2018"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0032","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1572-0241.2002.07057.x","article-title":"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients","volume":"97","author":"Fattovich","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0033","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications","volume":"53","author":"Benvegn\u00f9","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0034","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/jhep.2001.21905","article-title":"Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a national heart, lung, and blood institute collaborative study","volume":"33","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5694\/mja11.11531","article-title":"The changing therapeutic landscape for hepatitis C","volume":"196","author":"Dore","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0036","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0037","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0038","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/jcm9010222","article-title":"Targeting the host for new therapeutic perspectives in hepatitis D","volume":"9","author":"Turon-Lagot","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0039","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(82)90156-8","article-title":"Influence of delta infection on severity of hepatitis B","volume":"2","author":"Smedile","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0042","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jinf.2021.07.021","article-title":"Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms","volume":"83","author":"Wu","year":"2021","journal-title":"J Infect"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0043","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/jvh.13174","article-title":"HEV-LFS: a novel scoring model for patients with hepatitis E virus-related liver failure","volume":"26","author":"Wu","year":"2019","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0044","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/apt.14109","article-title":"Review article: hepatitis E-a concise review of virology, epidemiology, clinical presentation and therapy","volume":"46","author":"Donnelly","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/lt.23764","article-title":"Hepatitis E infection in liver transplant recipients","volume":"20","author":"Unzueta","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0046","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJMra1204512","volume":"367","author":"Hoofnagle","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0047","series-title":"Hepatitis E. World Health Organization","year":"2017"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0048","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3390\/v15081745","article-title":"Discovery of hepatitis E and its impact on global health: a journey of 44 years about an incredible human-interest story","volume":"15","author":"Khuroo","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0049","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-0033-1338116","article-title":"Development of the hepatitis E vaccine: from bench to field","volume":"33","author":"Zhang","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5769201","article-title":"Hepatitis E: update on prevention and control","volume":"2018","author":"Melga\u00e7o","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0051","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jvh.12445","article-title":"Hepatitis E: an emerging global disease - from discovery towards control and cure","volume":"23","author":"Khuroo","year":"2016","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0052","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41575-018-0014-9","article-title":"Noninvasive biomarkers in NAFLD and NASH - current progress and future promise","volume":"15","author":"Wong","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0053","doi-asserted-by":"crossref","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","article-title":"Non-invasive diagnosis of advanced fibrosis and cirrhosis","volume":"20","author":"Sharma","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0054","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1111\/liv.15515","article-title":"Diagnosis of HDV: from virology to non-invasive markers of fibrosis","volume":"43","author":"Majeed","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0055","first-page":"4S34","article-title":"Non invasive markers using for the assessment of fibrosis in hepatitis C","volume":"31","author":"Zarski","year":"2007","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0056","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/v13060951","article-title":"Novel biomarkers of hepatitis B virus and their use in chronic hepatitis B patient management","volume":"13","author":"Vachon","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0057","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/hep.31616","article-title":"HBV RNA profiles in patients with chronic hepatitis B under different disease phases and antiviral therapy","volume":"73","author":"Mak","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0058","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/hep.29872","article-title":"Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment","volume":"68","author":"van Campenhout","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0059","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2017.08.021","article-title":"Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients","volume":"68","author":"Wang","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0060","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/hep.30325","article-title":"Serum hepatitis B virus RNA: a new potential biomarker for chronic hepatitis B virus infection","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0061","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/v12121440","article-title":"miRNAs as potential biomarkers for viral hepatitis B and C","volume":"12","author":"Loureiro","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0062","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190900","article-title":"Diagnostic value of circulating miRNA-122 for hepatitis B virus and\/or hepatitis C virus-associated chronic viral hepatitis","volume":"39","author":"Zhou","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0063","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/genes14020441","article-title":"Serum microRNAs as predictors for HCV progression and response to treatment in Pakistani patients","volume":"14","author":"Manzoor","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0064","first-page":"223","article-title":"Evaluation of miR-222 expression in HBV infected patients in comparison with HDV and HBV co-infected patients","volume":"13","author":"Sokhanvar","year":"2021","journal-title":"Avicenna J Med Biotechnol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0065","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1038\/s41598-020-62159-9","article-title":"Specific circulating microRNAs during hepatitis E infection can serve as indicator for chronic hepatitis E","volume":"10","author":"Harms","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0066","article-title":"Expression changes of serum LINC00941 and LINC00514 in HBV infection-related liver diseases and their potential application values","volume":"36","author":"Chen","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0067","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinbiochem.2020.06.005","article-title":"Serum expression and diagnostic potential of long non-coding RNAs NEAT1 and TUG1 in viral hepatitis C and viral hepatitis C-associated hepatocellular carcinoma","volume":"84","author":"Mohyeldeen","year":"2020","journal-title":"Clin Biochem"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0068","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.3201\/eid2711.20462","article-title":"Hepatitis A virus incidence rates and biomarker dynamics for plasma donors, United States","volume":"27","author":"Schoch","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0069","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-13272-4","article-title":"Differential proteomic analysis of plasma-derived exosomes as diagnostic biomarkers for chronic HBV-related liver disease","volume":"12","author":"Ye","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0070","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1002\/jmv.27761","article-title":"Identification of potential plasma markers for hepatitis B virus-related chronic hepatitis and liver fibrosis\/cirrhosis","volume":"94","author":"Zhao","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0071","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/s12879-019-4130-0","article-title":"Potential circulating biomarkers of circulating chemokines CCL5, MIP-1\u03b2 and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0072","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/omi.2015.0037","article-title":"CHI3L1 is a liver-enriched, noninvasive biomarker that can be used to stage and diagnose substantial hepatic fibrosis","volume":"19","author":"Huang","year":"2015","journal-title":"OMICS"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0073","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.hbpd.2020.05.009","article-title":"Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China","volume":"19","author":"Jin","year":"2020","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0074","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2015.10.016","article-title":"Adiponectin: a biomarker for chronic hepatitis C?","volume":"89","author":"Liu","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0075","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4254\/wjh.v7.i1.44","article-title":"Adiponectin serum level in chronic hepatitis C infection and therapeutic profile","volume":"7","author":"Peta","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0076","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/MEG.0b013e32835fa988","article-title":"Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients","volume":"25","author":"Chen","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0077","doi-asserted-by":"crossref","first-page":"10449","DOI":"10.3748\/wjg.v20.i30.10449","article-title":"Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C","volume":"20","author":"W\u00f3jcik","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0078","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ejim.2015.08.001","article-title":"Increased circulating adiponectin in males with chronic HCV hepatitis","volume":"26","author":"Canavesi","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0079","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12876-022-02095-2","article-title":"Serum superoxide dismutase level is a potential biomarker of disease prognosis in patients with HEV-induced liver failure","volume":"22","author":"He","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0080","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1002\/jmv.27961","article-title":"The diagnostic and prognostic value of serum exosome-derived carbamoyl phosphate synthase 1 in HEV-related acute liver failure patients","volume":"94","author":"Xiang","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0081","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3892\/or.2016.5225","article-title":"Hepatitis B virus X protein sensitizes HL-7702 cells to oxidative stress-induced apoptosis through modulation of the mitochondrial permeability transition pore","volume":"37","author":"Gao","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0082","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/15548627.2016.1191857","article-title":"PRKAA\/AMPK restricts HBV replication through promotion of autophagic degradation","volume":"12","author":"Xie","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0083","article-title":"Adenosine triphosphate in serum as a promising biomarker for differential diagnosis of hepatitis B disease progression","volume":"13","author":"Lin","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0084","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046526","article-title":"Activation of the connective tissue growth factor (CTGF)-transforming growth factor \u03b21 (TGF-\u03b21) axis in hepatitis C virus-expressing hepatocytes","volume":"7","author":"Nagaraja","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0086","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.47665\/tb.37.4.1093","article-title":"Assessment of interleukin 17 and transforming growth factor-beta 1 in hepatitis C patients with disease progression","volume":"37","author":"Elbanan","year":"2020","journal-title":"Trop Biomed"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0087","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/prd.12116","article-title":"The physiology of salivary secretion","volume":"70","author":"Proctor","year":"2016","journal-title":"Periodontol 2000"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0088","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/CMR.00021-13","article-title":"Salivary biomarkers: toward future clinical and diagnostic utilities","volume":"26","author":"Yoshizawa","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0089","doi-asserted-by":"crossref","first-page":"177","DOI":"10.11613\/BM.2015.018","article-title":"Clinical and diagnostic utility of saliva as a non-invasive diagnostic fluid: a systematic review","volume":"25","author":"Nunes","year":"2015","journal-title":"Biochem Med (Zagreb)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2017.10.016","article-title":"Salivary immune proteins monitoring can help detection of binge and chronic alcohol drinkers: preliminary findings","volume":"183","author":"Waszkiewicz","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0091","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/alcalc\/agn027","article-title":"The effect of the binge drinking session on the activity of salivary, serum and urinary beta-hexosaminidase: preliminary data","volume":"43","author":"Waszkiewicz","year":"2008","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0092","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/odi.12692","article-title":"Comparison of oral fluid collection methods for the molecular detection of hepatitis B virus","volume":"23","author":"Portilho","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0093","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrgastro.2012.187","article-title":"Diagnosis of hepatitis E","volume":"10","author":"Aggarwal","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0094","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/zph.12472","article-title":"Detection of hepatitis E virus RNA in saliva for diagnosis of acute infection","volume":"65","author":"Rivero-Juarez","year":"2018","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0095","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1017\/S095026881900027X","article-title":"Oral fluid testing facilitates understanding of hepatitis A virus household transmission","volume":"147","author":"Haywood","year":"2019","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0096","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1096-9071(200008)61:4<433::AID-JMV4>3.0.CO;2-5","article-title":"Dynamic study of HBsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance","volume":"61","author":"Zhevachevsky","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0097","first-page":"174","article-title":"Saliva as a tool in the detection of hepatitis B surface antigen in patients","volume":"33","author":"Arora","year":"2012","journal-title":"Compend Contin Educ Dent"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0098","first-page":"419","article-title":"Detection of HbsAg and HBV DNA in serum and saliva of HBV carriers","volume":"31","author":"Noppornpanth","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0099","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4274\/vhd.galenos.2020.2020.0007","article-title":"Correlation between hepatitis C virus antibodies in saliva and serum: a safe method for epidemiological studies","volume":"26","author":"Eren Kutsoylu","year":"2020","journal-title":"Viral Hepat J"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0100","article-title":"Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma","volume":"12","author":"He","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0101","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/glycob\/cwy108","article-title":"Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma","volume":"29","author":"Zhang","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0102","doi-asserted-by":"crossref","first-page":"9003","DOI":"10.3390\/ijerph19159003","article-title":"Morphological changes in the oral mucous membrane in viral hepatitis C patients: a cross-sectional study","volume":"19","author":"Azatyan","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0103","first-page":"2381","article-title":"Interleukin-1\u03b1 and -1\u03b2 assessment in the gingival crevicular fluid of periodontal patients with chronic hepatitis C","volume":"20","author":"Surlin","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0104","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/14737159.2020.1743687","article-title":"Update on urine as a biomarker in cancer: a necessary review of an old story","volume":"20","author":"Zhang","year":"2020","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0105","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41416-022-01706-9","article-title":"Urine DNA biomarkers for hepatocellular carcinoma screening","volume":"126","author":"Kim","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0106","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11897-019-00444-z","article-title":"Utility of urine biomarkers and electrolytes for the management of heart failure","volume":"16","author":"Verbrugge","year":"2019","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0107","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17476348.2022.2090341","article-title":"Urine biomarkers of pulmonary tuberculosis","volume":"16","author":"Khimova","year":"2022","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.urolonc.2021.11.018","article-title":"Carcinogenic biomarkers of exposure in the urine of heated tobacco product users associated with bladder cancer: a systematic review","volume":"40","author":"Svendsen","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0109","first-page":"741","article-title":"Urinary metabolomic profiling in chronic hepatitis B viral infection using gas chromatography\/mass spectrometry","volume":"19","author":"Dittharot","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0110","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017143","article-title":"Expression and significance of urinary microRNA in patients with chronic hepatitis B","volume":"98","author":"Shang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0111","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejso.2021.06.015","article-title":"Urine miR-93-5p is a promising biomarker for early detection of HBV-related hepatocellular carcinoma","volume":"48","author":"Zhou","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0112","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/15257770.2021.1961272","article-title":"Urinary 8-oxo-7,8-dihydroguanosine levels are elevated in HCV-infected patients","volume":"40","author":"Zhang","year":"2021","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0113","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.32745","article-title":"Urine is a viral antigen reservoir in hepatitis E virus infection","volume":"77","author":"Ying","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0114","doi-asserted-by":"crossref","first-page":"G305","DOI":"10.1152\/ajpgi.00267.2019","article-title":"Urine \u03b1-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma","volume":"318","author":"Zhan","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0115","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","article-title":"The gut flora as a forgotten organ","volume":"7","author":"O\u2019Hara","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0116","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0117","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1111\/cas.15983","article-title":"Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma","volume":"114","author":"Zheng","year":"2023","journal-title":"Cancer Sci"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0118","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.3748\/wjg.v27.i33.5488","article-title":"Microbiota and viral hepatitis: state of the art of a complex matter","volume":"27","author":"Milosevic","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0119","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.3389\/fmicb.2017.02222","article-title":"Gut microbial dysbiosis is associated with altered hepatic functions and serum metabolites in chronic hepatitis B patients","volume":"8","author":"Wang","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0120","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1021\/acsinfecdis.0c00432","article-title":"Alterations of the treatment-naive gut microbiome in newly diagnosed hepatitis C virus infection","volume":"7","author":"Sultan","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13099-022-00501-4","article-title":"Potential impact of gut Lactobacillus acidophilus and Bifidobacterium bifidum on hepatic histopathological changes in non-cirrhotic hepatitis C virus patients with different viral load","volume":"14","author":"Ashour","year":"2022","journal-title":"Gut Pathog"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0122","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/jmv.27356","article-title":"Gut microbiota dysbiosis associated with plasma levels of interferon-\u03b3 and viral load in patients with acute hepatitis E infection","volume":"94","author":"Wu","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0123","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41597-024-03187-2","article-title":"Single-cell RNA-sequencing of virus-specific cellular immune responses in chronic hepatitis B patients","volume":"11","author":"Hatje","year":"2024","journal-title":"Sci Data"},{"key":"10.1016\/j.hbpd.2025.10.010_bib0124","article-title":"Single-cell RNA sequencing reveals the transcriptomic characteristics of peripheral blood mononuclear cells in hepatitis B vaccine non-responders","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"}],"container-title":["Hepatobiliary &amp; Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225001791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387225001791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T11:21:33Z","timestamp":1785237693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387225001791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1499387225001791"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.10.010","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive diagnostic biomarkers of viral hepatitis based on multi-omics technology: Recent advances and challenges","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2025.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}